Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.
about
The effect of iron supplement on children with euthyroid goiter: a randomized placebo-controlled clinical trial.Daily versus alternate day thyroxine therapy to maintain euthyroidism in children with congenital hypothyroidismAICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001-2002, a Cross-Sectional, Hypothesis-Generating Study.Oxidized LDL Is Strictly Limited to Hyperthyroidism Irrespective of Fat Feeding in Female Sprague Dawley RatsThe Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases.Association of apolipoprotein b/apolipoprotein A1 ratio and coronary artery stenosis and plaques detected by multi-detector computed tomography in healthy population.Cholesterol and cardiovascular disease in the elderly. Facts and gaps.Association Between Thyroid Hormones, Lipids and Oxidative Stress Markers in Subclinical Hypothyroidism.Newborn screening for autism: in search of candidate biomarkers.Serum Lipid Transfer Proteins in Hypothyreotic Patients Are Inversely Correlated with Thyroid-Stimulating Hormone (TSH) Levels.The relationships between thyroid hormones and thyroid-stimulating hormone with lipid profile in euthyroid men.The impact of high fat diets on physiological changes in euthyroid and thyroid altered rats.Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.
P2860
Q34234854-6C71A52A-F522-431F-84FF-453FA094C026Q34414628-D1EB3595-BF18-4A26-AB04-44A9848FB69EQ35560768-68371FEC-7F76-49D8-826D-B07226EE782EQ35607772-E40D6930-838D-4E38-AFCB-404776F84394Q35723946-22ED02CF-E88E-4A2C-92D7-1405992D5E90Q36825689-4F0F0475-BF21-4A01-8977-E69D541FC468Q36841091-AB6FD51B-B695-431F-A814-62C878AEA32BQ36863052-06194DCA-5369-431B-9134-8DC6A08EFD6CQ37041308-E0B2C6BF-1935-4A26-8DFE-2F83BD354E24Q37167836-5B4329A0-AD23-42B5-849E-72BE07A9C9E2Q37485394-EAA6387C-CEB0-4889-B799-43024BE94A51Q37605398-6D324814-F5E8-4BD2-9EEF-7057886D995DQ42099861-BEC3780A-B004-416B-A94F-C835C0D5901DQ42340155-AE520ACE-A790-4D31-BD16-F04D6B408E82
P2860
Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@ast
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@en
type
label
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@ast
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@en
prefLabel
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@ast
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@en
P2093
P2860
P356
P1433
P1476
Lipid abnormalities and cardio ...... d subclinical thyroid disease.
@en
P2093
George Dimitriadis
Grigoria Betsi
Melpomeni Peppa
P2860
P304
P356
10.1155/2011/575840
P577
2011-07-18T00:00:00Z